Statistics for ImmuCell (id:5867 ICCC)
Valuation metrics
Market cap
32.88M
Enterprise value
42.71M
Trailing P/E (ttm)
Forward P/E
-33.55
PEG ratio
-33.55
Price/Sales (ttm)
1.42
Price/Book (mrq)
1.14
Enterprise Value/Revenue
1.84
Enterprise Value/EBITDA
-67.40
Overview
Shares outstanding
8.91M
Float
4.71M
Shares short
4.01K
% Held by insiders
0.40%
% Held by institutions
0.15%
Average volume (10 days)
12.06K
Average volume (90 days)
Price summary
52-Week low
3.34
52-Week high
5.59
52-Week change
-26.56%
Beta
0.57
50-Day moving average
3.61
200-Day moving average
4.34
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
July 25th, 1990
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
-17.44%
Operating margin
-25.34%
Operational effectiveness
Return on assets
-4.87%
Return on equity
-16.10%
Income statement
Revenue (ttm)
2.99
Revenue per share (ttm)
2.99
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-633,697.00
Net income to common (ttm)
-4,049,325.00
Diluted EPS (ttm)
-0.49
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
1.32M
Total cash per share (mrq)
0.17
Total debt (mrq)
15.84M
Total Debt/Equity (mrq)
67.52
Current ratio (mrq)
236.90%
Book value per share (mrq)
3.22
Cash flow
Cash flow statement
-230,540.00
Levered free cash flow (LFCF)
522.36K